KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $214.0 million.

  • Medtronic's Change in Receivables fell 2646.05% to $214.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $178.0 million, marking a year-over-year decrease of 6087.91%. This contributed to the annual value of $433.0 million for FY2025, which is 1074.17% up from last year.
  • As of Q4 2025, Medtronic's Change in Receivables stood at $214.0 million, which was down 2646.05% from -$288.0 million recorded in Q3 2025.
  • Medtronic's 5-year Change in Receivables high stood at $435.0 million for Q4 2022, and its period low was -$288.0 million during Q3 2025.
  • Over the past 5 years, Medtronic's median Change in Receivables value was $96.5 million (recorded in 2021), while the average stood at $94.8 million.
  • Examining YoY changes over the last 5 years, Medtronic's Change in Receivables showed a top increase of 23206.11% in 2022 and a maximum decrease of 32250.0% in 2022.
  • Over the past 5 years, Medtronic's Change in Receivables (Quarter) stood at $131.0 million in 2021, then skyrocketed by 232.06% to $435.0 million in 2022, then tumbled by 35.4% to $281.0 million in 2023, then rose by 3.56% to $291.0 million in 2024, then decreased by 26.46% to $214.0 million in 2025.
  • Its Change in Receivables was $214.0 million in Q4 2025, compared to -$288.0 million in Q3 2025 and $249.0 million in Q2 2025.